
Last Price
52 Week Range
$1.05 - $5.65
Next Earnings Date
-
Next Earnings Date
-
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Acrivon Therapeutics, Inc. | 10-K | March 19, 2026 | |
Acrivon Therapeutics, Inc. | 8-K | March 19, 2026 | |
Acrivon Therapeutics, Inc. | 8-K | March 2, 2026 | |
Acrivon Therapeutics, Inc. | 8-K | February 27, 2026 | |
Acrivon Therapeutics, Inc. | 8-K | January 8, 2026 | |
Acrivon Therapeutics, Inc. | 8-K | January 8, 2026 | |
Acrivon Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | November 13, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | September 5, 2025 | |
Acrivon Therapeutics, Inc. | 10-Q | August 13, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | August 13, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | June 13, 2025 | |
Acrivon Therapeutics, Inc. | 10-Q | May 14, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | May 14, 2025 | |
Acrivon Therapeutics, Inc. | ARS | April 25, 2025 | |
Acrivon Therapeutics, Inc. | DEF 14A | April 25, 2025 | |
Acrivon Therapeutics, Inc. | DEFA14A | April 25, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | April 7, 2025 | |
Acrivon Therapeutics, Inc. | 10-K | March 27, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | March 27, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | March 25, 2025 | |
Acrivon Therapeutics, Inc. | 8-K | March 14, 2025 | |
Acrivon Therapeutics, Inc. | 10-Q | November 13, 2024 | |
Acrivon Therapeutics, Inc. | 8-K | November 13, 2024 | |
Acrivon Therapeutics, Inc. | 8-K | October 11, 2024 | |
Acrivon Therapeutics, Inc. | 8-K | September 16, 2024 | |
Acrivon Therapeutics, Inc. | 10-Q | August 13, 2024 | |
Acrivon Therapeutics, Inc. | 8-K | August 13, 2024 | |
Acrivon Therapeutics, Inc. | 8-K | June 21, 2024 | |
Acrivon Therapeutics, Inc. | 10-Q | May 14, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers